Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Novaccess Global Inc XSNX

NovAccess Global Inc. is a biopharmaceutical company, which develops immunotherapies to treat brain tumor patients in the United States. The Company specializes in research related to utilizing a patient’s own immune system to attack the cancer. Its dendritic cell-based immunotherapy utilizes a combination of Toll-like receptor adjuvants for an enhanced antitumor response. The therapy is designed to utilize the patient’s tumor antigens and immune cells, dendritic cells, in combination with TLR adjuvants to initiate an efficient antitumor immune response. This process includes obtaining the patients' tumor cells after surgery, and precursors cells that are matured into dendritic cells from peripheral blood. Its TLR-AD1 platform technology is a vaccine immunotherapy for the treatment of aggressive brain cancers, including glioblastoma and other high-grade gliomas. TLR-AD1 technology has a scope of use and is embodied in various different product lines for different clinical situations.


OTCPK:XSNX - Post by User

Post by LittleFundson Jan 11, 2018 9:09pm
147 Views
Post# 27338556

Sessions = drop

Sessions = dropI think peanut is right... It appears some big money may be moving in, accumulating shares from the weak hands that bought in at the start of the month. The sessions statement has scared alot of ppl and pushed them away for now.. it's only a matter of time before the sessions situation is dealt with and we can move on.. USA MJ is there to stay and sessions needs to deal with it or get out. There is still a worry that there is more to come from him, is probly the reason for the selling, however there's still something going on behind the scenes I feel as there are games being played with the ask/bid as peanut mentioned. Someone is still buying, look at ghr volume. And remember, this company has been around for along time, just because this MJ stuff came up doesn't mean they don't have other things going for them. With or without MJ this company should be on the move. Once that patent comes through it could also be the start of a rise in SP. I belive this company he huge potential, should be a great year..
<< Previous
Bullboard Posts
Next >>